Pacira Pharmaceuticals shares owned by Schroder Investment Management Group
Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by Schroder Investment Management Group
from 13F filings
Historical chart of Schroder Investment Management Group investment in Pacira Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Pacira Pharmaceuticals held by Schroder Investment Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Pacira Pharmaceuticals by Schroder Investment Management Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $18M | 617k | 28.61 |
| 2024-03-31 | $18M | 605k | 29.22 |
| 2023-12-31 | $21M | 622k | 33.74 |
| 2023-09-30 | $21M | 668k | 30.68 |
| 2023-06-30 | $34M | 839k | 40.07 |
| 2023-03-31 | $28M | 680k | 40.81 |
| 2022-12-31 | $26M | 681k | 38.61 |
| 2022-09-30 | $36M | 683k | 53.19 |
| 2022-06-30 | $34M | 577k | 58.30 |
| 2022-03-31 | $53M | 696k | 75.68 |
| 2021-12-31 | $39M | 644k | 60.17 |
| 2021-09-30 | $27M | 487k | 56.00 |
| 2021-06-30 | $34M | 560k | 60.68 |
| 2021-03-31 | $40M | 566k | 70.09 |
| 2020-12-31 | $31M | 509k | 59.84 |
| 2020-09-30 | $35M | 589k | 59.59 |
| 2020-06-30 | $36M | 680k | 52.47 |
| 2020-03-31 | $26M | 819k | 32.00 |
| 2019-12-31 | $41M | 910k | 45.30 |
| 2019-09-30 | $32M | 792k | 40.00 |
| 2019-06-30 | $32M | 733k | 43.49 |
| 2019-03-31 | $28M | 724k | 38.06 |
| 2018-12-31 | $42M | 981k | 43.02 |
| 2018-09-30 | $48M | 978k | 49.15 |
| 2018-06-30 | $18M | 521k | 34.55 |
| 2018-03-31 | $38M | 1.2M | 31.15 |
| 2017-12-31 | $45M | 980k | 45.65 |
| 2017-09-30 | $37M | 947k | 38.70 |
| 2017-06-30 | $45M | 935k | 48.20 |
| 2017-03-31 | $43M | 929k | 45.85 |
| 2016-12-31 | $24M | 754k | 32.30 |
| 2016-09-30 | $23M | 664k | 34.22 |
| 2016-06-30 | $16M | 479k | 33.73 |
More positions owned by Schroder Investment Management Group
View all positions for Schroder Investment Management Group